{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:59:49Z","timestamp":1785149989618,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Early hemodynamic deterioration may occur in patients with acute decompensated heart failure (ADHF) receiving inotropic therapy despite the absence of overt hypoperfusion at baseline. This study aimed to identify baseline factors associated with progression from Society for Cardiovascular Angiography and Interventions (SCAI) stage A or B to SCAI stage C\u2013E at 72 h after initiation of inotropic therapy. Methods: This retrospective, single-center study included 375 adults with ADHF who received intravenous dobutamine or levosimendan and were classified as SCAI stage A or B at the time of inotrope initiation. The primary endpoint was progression to SCAI stage C, D, or E at the 72 h assessment. Baseline clinical, echocardiographic, laboratory, and hemodynamic variables were compared according to progression status. Univariable and multivariable logistic regression analyses were performed to identify factors associated with the primary endpoint. Results: Progression to SCAI stage C\u2013E occurred in 30 patients (8.0%). Patients who progressed had lower diastolic blood pressure (DBP) and higher heart rate, white blood cell count (WBC), C-reactive protein, aspartate aminotransferase, lactate dehydrogenase, and N-terminal pro-B-type natriuretic peptide levels. The primary multivariable logistic regression model included 327 patients and all 30 outcome events. Higher WBC was independently associated with greater odds of progression (odds ratio: 1.099; 95% confidence interval: 1.030\u20131.174; p = 0.005), whereas higher DBP was independently associated with lower odds of progression to SCAI stage C\u2013E (odds ratio: 0.963; 95% confidence interval: 0.934\u20130.992; p = 0.014). The model showed acceptable calibration and moderate discrimination, with a c-statistic of 0.731 (95% confidence interval: 0.630\u20130.832). In bootstrap analysis, the association remained significant for WBC, whereas the association with DBP was borderline. Conclusions: Higher WBC and lower DBP were associated with progression to SCAI stage C\u2013E at 72 h in this exploratory single-center cohort of patients with ADHF receiving inotropic therapy.<\/jats:p>","DOI":"10.3390\/jcm15155816","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:47:41Z","timestamp":1785145661000},"page":"5816","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Progression to SCAI-Defined Hemodynamic Instability at 72 Hours in Patients with Acute Decompensated Heart Failure Receiving Inotropic Therapy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-205X","authenticated-orcid":false,"given":"Rauf","family":"Avc\u0131","sequence":"first","affiliation":[{"name":"Turkish Ministry of Health Antalya Training and Research Hospital, 07100 Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-5075","authenticated-orcid":false,"given":"G\u00fcls\u00fcm Meral","family":"Y\u0131lmaz \u00d6ztekin","sequence":"additional","affiliation":[{"name":"Turkish Ministry of Health Antalya Training and Research Hospital, 07100 Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15420\/cfr.2019.11.2","article-title":"Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice","volume":"5","author":"Bistola","year":"2019","journal-title":"Card. Fail. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100524","DOI":"10.1016\/j.ahjo.2025.100524","article-title":"The current use of vasoactive agents in cardiogenic shock related to myocardial infarction and acute decompensated heart failure","volume":"52","author":"Becerra","year":"2025","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","first-page":"E213","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"ref_5","first-page":"1339","article-title":"Prospective validation of the SCAI shock classification: Single center analysis","volume":"96","author":"Baran","year":"2020","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","first-page":"E288","article-title":"SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome","volume":"97","author":"Pareek","year":"2021","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5603\/KP.a2016.0147","article-title":"Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: Data from a large single-centre cohort","volume":"75","author":"Ostrowska","year":"2017","journal-title":"Kardiol. Pol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17828","DOI":"10.1038\/s41598-017-17754-8","article-title":"Hemographic indices are associated with mortality in acute heart failure","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/cvr\/cvad088","article-title":"Acute heart failure: Mechanisms and pre-clinical models\u2014A scientific statement of the ESC Working Group on Myocardial Function","volume":"119","author":"Ciccarelli","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: From pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized with Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e007924","DOI":"10.1161\/CIRCHEARTFAILURE.120.007924","article-title":"Clinical Outcomes Associated with Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock","volume":"14","author":"Sinha","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacc.2024.04.069","article-title":"Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report","volume":"84","author":"Ton","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ejhf.308","article-title":"Early vs. late worsening heart failure during acute heart failure hospitalization: Insights from the PROTECT trial","volume":"17","author":"Mentz","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2022.04.049","article-title":"Criteria for Defining Stages of Cardiogenic Shock Severity","volume":"80","author":"Kapur","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00380-021-01788-0","article-title":"Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction","volume":"36","author":"Fuchida","year":"2021","journal-title":"Heart Vessels"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e012847","DOI":"10.1161\/CIRCHEARTFAILURE.125.012847","article-title":"Diastolic Perfusion Pressure Predicts Response to Inotropes and Vasopressors and Benefit from Mechanical Circulatory Support in Cardiogenic Shock","volume":"18","author":"Lim","year":"2025","journal-title":"Circ. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5816\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:06:06Z","timestamp":1785146766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":22,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15155816"],"URL":"https:\/\/doi.org\/10.3390\/jcm15155816","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]}}}